Novartis Ag (NVS) Cash from Operations (2009 - 2026)
Novartis Ag's Cash from Operations came in at $5.88 billion for Q2 2026, down 11.7% from $6.66 billion a year earlier but up 60.0% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Cash from Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Cash from Operations of $18.39 billion, down 11.5% year-over-year; for FY2025, it was $19.14 billion, up 8.7% from FY2024.
- Cash from Operations has increased in each of the last four years, with a five-year compound annual growth rate of 7.0% (FY2020 to FY2025).
- Going back by year, Cash from Operations was $17.62 billion in FY2024 (+9.3%), $16.12 billion in FY2023 (+10.4%), $14.61 billion in FY2022 (+9.3%) and $13.37 billion in FY2021 (-2.1%).
- The five-year range for quarterly Cash from Operations is $1.65 billion (Q1 2022) to $6.66 billion (Q2 2025).
- Year-over-year, Cash from Operations increased in six of the last eight quarters, with growth averaging 11.4%.
- The fastest year-over-year change in Cash from Operations over five years came in Q1 2023 (growth of 188.2%), and the weakest in Q1 2024 (a decline of 52.3%).
- Business Quant data shows NVS's Cash from Operations at $3.68 billion (Q1 2026), $2.26 billion (Q4 2025) and $6.57 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Vertex Pharmaceuticals | 133.42 Bn | 105.43 Bn | 2.84 Bn | 1.13 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.88 Bn |
| Mar 31, 2026 | 3.68 Bn |
| Dec 31, 2025 | 2.26 Bn |
| Sep 30, 2025 | 6.57 Bn |
| Jun 30, 2025 | 6.66 Bn |
| Mar 31, 2025 | 3.65 Bn |
| Dec 31, 2024 | 4.19 Bn |
| Sep 30, 2024 | 6.29 Bn |
| Jun 30, 2024 | 4.88 Bn |
| Mar 31, 2024 | 2.27 Bn |
| Dec 31, 2023 | 2.55 Bn |
| Sep 30, 2023 | 5.38 Bn |
| Jun 30, 2023 | 3.58 Bn |
| Mar 31, 2023 | 2.96 Bn |
| Dec 31, 2022 | 4.11 Bn |
| Sep 30, 2022 | 4.72 Bn |
| Jun 30, 2022 | 3.76 Bn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 3.88 Bn |
| Sep 30, 2021 | 4.93 Bn |
API Access
Novartis Ag Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();